Stay updated on Ampyra Optic Neuritis in MS Clinical Trial
Sign up to get notified when there's something new on the Ampyra Optic Neuritis in MS Clinical Trial page.

Latest updates to the Ampyra Optic Neuritis in MS Clinical Trial page
- Check3 days agoChange DetectedThe Study Record Dates area now displays revision v3.7.0, replacing the previous v3.6.6, which indicates an update to the page template or system version rather than a change to the study data.SummaryDifference0.1%

- Check10 days agoNo Change Detected
- Check17 days agoChange DetectedThe page's revision tag was updated from v3.6.5 to v3.6.6, indicating a small update to the page's revision history.SummaryDifference0.1%

- Check24 days agoNo Change Detected
- Check38 days agoChange DetectedRevision: v3.6.5 now appears on the page, replacing the previous Revision: v3.6.4. This represents a minor maintenance update to the study details page and does not change the study content or user-facing information.SummaryDifference0.1%

- Check52 days agoChange DetectedRevision updated from v3.6.3 to v3.6.4 in the page footer, indicating a software update to the ClinicalTrials.gov interface. This change does not modify any study content or results.SummaryDifference0.1%

- Check80 days agoChange DetectedThe site's revision label was updated from v3.6.0 to v3.6.3, indicating a platform update. This update does not alter the study details or other user-facing content.SummaryDifference0.1%

- Check95 days agoChange DetectedThe page now shows 'No longer looking for participants,' indicating recruitment has closed, and new help/navigation sections such as 'How to Read a Study Record,' 'Common Questions,' and 'How to Join a Study' have been added. The 'Intervention/Treatment' heading formatting has been updated and the revision version has been bumped from v3.5.5 to v3.6.0.SummaryDifference0.4%

Stay in the know with updates to Ampyra Optic Neuritis in MS Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Ampyra Optic Neuritis in MS Clinical Trial page.